drug · antibody
patient view →ramucirumab
Phase 3updated 2mo agoby Eli Lilly and Co🔗 ChEMBL
Phase 3community read0 votes
Antibody drug with a maximum clinical stage of Approval (across all indications), with 6 approved and 18 investigational indications.
indications
indications
NSCLC
targets
Vascular endothelial growth factor receptor 2
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that